Brian Berman, MD, PhD < Back Brian Berman, MD, PhD Faculty Professor Emeritus of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine, Miami, FL Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL Senior Scientific Advisor and Acting Chief Medical OfficerBerg Health, Framingham, MA Dr. Brian Berman is Professor Emeritus of Dermatology and Dermatologic Surgery at The University of Miami Miller School of Medicine and has had the honor of serving as a member of the Board of Directors and Vice President of the American Academy of Dermatology. He is Past President of the American Dermatological Association. Dr. Berman is Secretary of the American Cutaneous Oncology Society, Secretary of the American Hyperhidrosis Medical Society, past President and the Founder of The National Association of Veterans Affairs Dermatologists, and serves on the Scientific Advisory / Editorial Boards of The European Journal of Dermatology, SKINmed, Journal of Clinical and Aesthetic Dermatology, Dermatology Digest, and SKIN, and edited The Miami Review series. In addition to caring for patients at Skin and Cancer Associates in Aventura, FL, Dr. Berman is Co-Director of the Center for Clinical and Cosmetic Research, continuing his broad-based clinical research program while focusing on the study of the control of scarring and skin cancer. He has presented at over 300 local, regional, state, national and international dermatologic societies and conferences and authored of more than 250 peer-reviewed scientific and clinical articles, chapters and books. In 2021 the Florida Society of Dermatology and Dermatologic Surgery recognized Dr. Berman as “Practitioner of the Year.” D. Berman serves as Senior Scientific Advisor and Acting Chief Medical Officer at Berg Health, a clinical-stage, AI-powered biotechnology company. PS Home

Antoanella Calame, MD Antoanella Calame, MD Faculty Dr. Antoanella Calame received her MD degree from University of California, San Diego (UCSD) after graduating Summa Cum Laude from California Lutheran University. She completed her residency in Dermatology at UCSD, followed by a Dermatopathology Fellowship at University of Texas, Southwestern (UTSW) in Dallas, Texas, where she trained with Dr. Clay Cockerell, one of the world leaders in the field of Dermatopathology. Dr. Calame is board certified in Dermatology and Dermatopathology and holds over thirty active state licenses. She is the author of a book on Cutaneous Manifestations of HIV disease and has published numerous peer reviewed scientific papers. Dr. Calame is an invited speaker at local and national conferences every year. She has a special interest in melanoma and melanocytic lesions and is actively involved with the newest clinical and molecular techniques used in the diagnosis and prognosis of cutaneous melanoma. Dr. Calame is the founder and director of Compass Dermatopathology, Poway Dermatology, and the Dermatology Center of La Jolla. She practices Dermatopathology full time and spends a limited time seeing Dermatology patients. Dr. Calame teaches Dermatology and Dermatopathology to the UCSD and Navy Dermatology residents, as well as Dermatology and Pathology residents who come to rotate with her from all over the United States and the world. She has received the annual Excellence in Teaching Award from UTSW and UCSD four times. Dr. Calame’s interests outside of work include tennis, yoga, camping, and spending time with her family. PS Winter Home

Business 201 Faculty < Back Jeff Libby Partner Jeff Libby is more than an outstanding attorney and counselor; he is a trusted advisor. Jeff's practice focuses on commercial real estate and commercial loan transactions in which he assists clients on a local and national basis in a wide array of development, leasing, lending and construction matters. Mr. Libby works alongside developers of medical office buildings, retail shopping centers, multifamily complexes and single-family lots assisting with site acquisition, due diligence, subdivision and platting, zoning, entitlements and financing, as well as the construction of improvements, leasing, management and asset disposition. Jeff helps landlords and tenants successfully negotiate their commercial lease agreements, and counsels owners and contractors throughout the construction process. Mr. Libby also assists local community banks and national institutional lenders in processing and closing commercial loan transactions. Specialties Include: Commercial Real Estate Transactions Commercial Loan Transactions Commercial Lending Site Acquisition and Disposition Sale-Leaseback Transactions Medical Office Building Development Retail Development Mixed Use Development, Shopping Center Development Office Building Development Multifamily Development Single-Family Development Leasing (Landlord / Tenant) Medical Office Leasing Retail Leasing Shopping Center Leasing Commercial Office Leasing Industrial Leasing Warehouse Leasing Construction (Owner, Contractor, Subcontractor) Entitlements and Zoning Business Loan Transactions (Lender / Borrower) Commercial Mortgage Loans (Lender / Borrower) Title and Survey Easements Covenants, Conditions and Restictions (CCRs) Deed Restrictions Owner Associations Business Transactions Corporate Transactions https://www.libbysparks.com/ Business201 Home

Chris Bandel < Back Chris Bandel Educational Manager Cockerell Dermatopathology , Dermatopathologist Assistant Dermpath On Demand, Co-Educational Manager Bio coming soon. DOD Home

Whitney High, MD, JD, MEng Whitney High, MD, JD, MEng Faculty Professor of Dermatology Vice-Chairman, Dermatology Director of Dermatology Clinic Director of Dermatopathology Laboratory, University of Colorado Whitney A. High, MD, MEng, a native of Colorado, is the Vice Chairman of Dermatology, and the Director of both the Dermatology Clinic and the Dermatopathology Laboratory at the University of Colorado. He is board-certified in Dermatology and Dermatopathology. He also has certification in Tropical Medicine & Hygiene. After practicing as a chemical engineer in the industry, Dr. High returned to medical school to receive his medical degree from the Mayo Clinic School of Medicine. Dr. High completed his dermatology residency training at the University of Texas Southwestern Medical Center, serving as Chief Resident. He completed his dermatopathology fellowship at the University of Colorado. Dr. High is appointed to the Departments of Dermatology & Pathology at the University of Colorado. His research laboratory was the first in the world to discover gadolinium in the tissue of patients with nephrogenic systemic fibrosis. Dr. High also has a degree in law from the University of Denver. He has authored 4 textbooks, 40 chapters, and more than 80 medical papers. He has served as an editor/editorial board member in many top medical journals in his fields. Dr. High’s current research interests include: Pigmented lesions Medicolegal issues Infectious disease/sexually transmitted disease Pharmacological and toxicological dermatology/dermatopathology Advanced biochemical testing applied to dermatology/dermatopathology PS Winter Home

Adam Rubin, MD < Back Adam Rubin, MD Faculty University of Pennsylvania Associate Professor of Dermatology at the Hospital of the University of Pennsylvania Associate Professor of Dermatology in Pathology and Laboratory Medicine Associate Professor of Dermatology in Pediatrics PS Home

Business 201 Faculty < Back Clay Cockerell, MD, MBA, JD President & Founder Cockerell Dermatopathology , Founder & President Health Education Services sponsored by Lake Granbury Medical Center, Program Director, Residency Program Dermpath On Demand , Co-Founder & Educational Director Dr. Clay J. Cockerell is a world-renowned specialist in treating and diagnosing skin disorders and has diagnosed over three million biopsies. An internationally recognized pioneer in his field and double board-certified in dermatology and dermatopathology, Dr. Cockerell has been practicing medicine since 1986. He is currently the Founder & President of Cockerell Dermatopathology and the Program Director of the Health Education Services dermatology residency program sponsored by the Lake Granbury Medical Center. Also, Dr. Cockerell sees patients a few days per month to assist with resident training and to keep his clinicopathological skills sharp. Dr. Cockerell has held numerous leadership positions within several highly regarded medical associations. Most notably, he served as the President, Secretary & Treasurer and a member of the Board of Directors of the American Academy of Dermatology, President of the Texas Dermatological Society, and President of the Dallas Dermatological Society. Also, Dr. Cockerell holds leadership roles as Founder and President of Cockerell Dermatopathology and a former AmeriPath Board of Directors member. Dr. Cockerell and his wife, Brenda, had a lifelong dream of producing wine and, in 2005, purchased a vineyard in Calistoga, California. They now produce wine under the Coquerel Family Wine Estates label. Dr. Cockerel and Brenda have two children, Charles and Lillian, and they have been married for forty-six years. In addition, Dr. Cockerell and Brenda enjoy traveling, golf, and winter sports. http://www.dermpath.com Business201 Home

Jeffrey Callen, MD Jeffrey Callen, MD Faculty Board Certifications: Internal Medicine and Dermatology Medical Degree: University of Michigan Residencies: Internal Medicine and Dermatology – University of Michigan Special Areas of Expertise: Skin Signs of Systemic Diseases, Lupus Erythematosus,Dermatomyositis, Pyoderma Gangrenosum, Psoriasis and Systemic Therapies for Management of Skin Disease. Author of multiple dermatology articles and textbooks Affiliations: Chief, Division of Dermatology, University of Louisville Dr. Callen has served as the editor or deputy editor of several dermatology periodicals and is currently the Editor of the Dermatology Section of Up To Date. PS Winter Home

Mark Nestor, MD, PhD < Back Mark Nestor, MD, PhD Faculty Mark S. Nestor, M.D., Ph.D., F.A.A.D. is a board-certified Dermatologist and serves as Director of the Center for Clinical and Cosmetic Research™ and the Center for Cosmetic Enhancement®, Aventura, Florida. He is a Voluntary Professor in the Department of Dermatology and Cutaneous Surgery and the Department of Surgery, Division of Plastic Surgery at the University of Miami, Miller School of Medicine. He is the current President of the American Cutaneous Oncology Society, a past President of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and the Florida Society of Dermatology and Dermatologic Surgery. As Director for CCCR, he has conducted more than 150 FDA and non-FDA clinical trials. Dr. Nestor is recognized as a world expert in clinical therapeutics, drug delivery systems, and research in many areas of clinical Dermatology and aesthetics including acne, psoriasis, and skin cancer, light therapies to treat skin disease, cutaneous laser surgery, photodynamic therapy, and Superficial Radiation Therapy. His aesthetic expertise includes lasers, RF, and other devices, fillers and he recently developed new clinical postulates for botulinum toxins. He has authored over 100 articles and book chapters, has delivered over 1000 major presentations around the world, and is viewed as an internationally acclaimed lecturer and instructor of clinical and aesthetic dermatology. Dr. Nestor also serves as a consultant to numerous pharmaceutical and device companies assisting them in the development of new medications, devices, and cosmeceuticals. He received his MD and PhD in Immunopathology from UCLA School of Medicine and completed his Dermatology Residency at NYU. PS Home

The COVID-19 pandemic has transformed the business environment for good.Top PR Strategies < Back Top PR Strategies Angela Kambarian | Dermatology Authority Feb 1, 2022 The COVID-19 pandemic has transformed the business environment for good. Now that we are coming off one of the most disruptive years in history, we should probably come to terms with the fact that we might be operating in a business environment that has been transformed for good. Influenced by the prolonged pandemic and rapid technological advancements, we will be a wide variety of new strategies emerging in business to business (B2B) and business to consumer (B2C) marketing. Here are a few to keep in mind as we transition to 2022. Media Outlets Are Relying More on Contributed Articles Since 2008, newsroom employment in the U.S. has fallen 26%, and demand for online content has grown exponentially. It means that media outlets have fewer full-time writers, resulting in increased demand for contributed articles by outside authors – the kind of thought leadership that is highly effective with B2B buyers. By the way, if you have been struggling to convince your executive team to invest the time and effort required for strong thought leadership, 2022 should be your year to change this. PR Professionals Will Use a Variety of Channels to Identify Media Opportunities From Muck Rack and Help a Reporter (HARO) to Twitter and Slack channels, it is easier for PR pros to respond and pitch via a plethora of new emerging platforms and channels. And that’s what digital transformation is all about. Public Relations Campaign Needs a Purpose In 2020 many brands were being heavily scrutinized or criticized for outdated policies, a lack of diversity in the workplace, or reluctance to get involved in social issues and make a difference. In 2021, however, many organizations had finally upgraded their policies, revamped or re-introduced DEI programs, openly expressed outrage over social injustices, and promised to step up their game. In 2022 brands should highlight their mission-based efforts across different communication channels and demonstrate more accountability. Public relation (PR) efforts should be focused on philanthropic involvement and social awareness; it’s crucial that businesses start transitioning from “talking the talk” to “walking the walk” and following through on “do-better” initiatives. Podcast Appearances Should No Longer Be Swept Under the Rug While local and national radio is still best for breaking news, podcasts seem more appropriate for extended discussions of hot topics. These podcasts may not have a vast number of listeners; however, those who do tune in will be highly engaged. If you were putting your appearance on a podcast on the back burner, it is time to give it some serious consideration. Impactful PR Will Have to be Part of a Larger Marketing Ecosystem PR usually generates more traction when combined with other marketing strategies. Let me assure you that in 2022 this will be vital. PR is a piece of the marketing puzzle and needs to be combined with a strong content strategy, paid ads strategy, and social strategy for bigger, better, and more powerful results. Keep it Simple We are living in turbulent and unpredictable times. Sadly, attention spans are short, and anxiety levels are sky-high these days. But the most crucial and impactful form of communication is also the most overlooked. Therefore, in my professional opinion, simplifying a brand message will be one of the important trends in PR for 2022. Companies of all sizes should make sure they avoid fancy language, long-winded copy, and tedious or complicated explanations. Keep your story short. Make it concise, easy-to-understand, and void of “highfalutin” terms. Just explain briefly what it is you do, why it matters, and how your prospects will benefit. ABOUT AUTHOR Angela Kambarian Kambarian.com | 516-724-4372 ABOUT CLAY J. COCKERELL, MD, JD, MBA Dr. Clay J. Cockerell is a world-renowned specialist in treating and diagnosing skin disorders and has diagnosed over three million biopsies. An internationally recognized pioneer in his field and double board-certified in dermatology and dermatopathology, Dr. Cockerell has been practicing medicine since 1986. He is currently the Founder & President of Cockerell Dermatopathology and the Program Director of the Health Education Services dermatology residency program sponsored by the Lake Granbury Medical Center. Also, Dr. Cockerell sees patients a few days per month to assist with resident training and to keep his clinicopathological skills sharp. Dr. Cockerell has held numerous leadership positions within several highly regarded medical associations. Most notably, he served as the President, Secretary & Treasurer and a member of the Board of Directors of the American Academy of Dermatology, President of the Texas Dermatological Society, and President of the Dallas Dermatological Society. Also, Dr. Cockerell holds leadership roles as Founder and President of Cockerell Dermatopathology and a former AmeriPath Board of Directors member. Dr. Cockerell and his wife, Brenda, had a lifelong dream of producing wine and, in 2005, purchased a vineyard in Calistoga, California. They now produce wine under the Coquerel Family Wine Estates label. Dr. Cockerel and Brenda have two children, Charles and Lillian, and they have been married for forty-six years. In addition, Dr. Cockerell and Brenda enjoy traveling, golf, and winter sports. ABOUT COCKERELL DERMATOPATHOLOGY The Cockerell Dermatopathology story begins with Dr. Clay J. Cockerell's vision to establish a practice whose mission is to treat each specimen as if it came from one of own family members. Family! At Cockerell Dermatopathology, every employee is driven by a relentless pursuit of diagnostic excellence. We specialize in evaluating dermatologic disorders, tackling cases ranging from the routine to the most challenging. Our practice continuously invests in cutting-edge technologies to best serve each referring clinician and their patients. These innovations result in higher-quality diagnostic slides, quicker turnaround times for routine cases, and seamless deployment of EMR interfaces. From an educational perspective, Cockerell Dermatopathology is more than a dermatopathology practice. We host numerous in-person and internet-based education events and boast a state-of-the-art 14-headed microscope for dermatology resident training sessions. Our services extend beyond borders, serving hundreds of clinicians in Texas, throughout the United States, and globally. With a highly accessible team of board-certified dermatopathologists and a dedicated support staff, our vision is simple yet profound. Family, we treat every specimen as if it were from one of our own family members. Previous Next

Philip LeBoit, MD < Back Philip LeBoit, MD Faculty Professor of Pathology and Dermatology Division Chief of UCSF Dermatopathology and Oral Pathology Service After training in Anatomic Pathology at the University of California, San Francisco and in Dermatopathology at both New York University (under the late Bernard Ackerman, M.D.) and at New York Hospital-Cornell Medical Center (with N. Scott McNutt, M.D.), Dr. LeBoit founded the UCSF Dermatopathology and Oral Pathology Service in 1987, with the goal of bringing academic expertise to a larger patient base than that of traditional university-based dermatopathology sections. Dr. LeBoit's investigative work includes the delineation of granulomatous slack skin as a lymphoma, the first comprehensive description of bacillary angiomatosis and bacillary peliosis hepatis, the development of the concept of palisaded neutrophilic and granulomatous dermatitis, the application of first morphometric and then molecular studies to melanocytic neoplasms and the initial description of nephrogenic systemic fibrosis. Dr. LeBoit has written over 250 peer reviewed publications, over 25 book chapters, and co-edited the dermatology textbook, Cutaneous Medicine and Surgery. Another major project for the World Health Organization was editing the WHO "blue book" Skin Tumors. Dr. Massi and Dr. LeBoit authored the textbook, Histologic Diagnosis of Nevi and Melanoma, the second edition of which was published in 2014. Dr. LeBoit has given over 400 invited lectures in North and South America, Europe and Asia. Dr. LeBoit served as editor-in-chief of the American Journal of Dermatopathology from 1997-2006, served as an associate editor of the Journal of Investigative Dermatology, and am currently an editor of Seminars in Cutaneous Medicine and Surgery. Dr. LeBoit's service to the International Society of Dermatopathology includes membership on the executive committee and terms as Secretary-Treasurer and as President of the Society (2004-7). Dr. LeBoit have received the Ackerman Award from the International Society of Dermatopathology, and am the only person who has received both the Founders Award and the Pinkus Award from the American Society of Dermatopathology. PS Home

Lawrence Schachner, MD < Back Lawrence Schachner, MD Faculty Bio coming soon. PS Home